| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $19.0M | 500,000 | 8.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $18.1M | 235,000 | 7.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.9M | 130,000 | 6.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $15.5M | 300,000 | 6.6% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $13.3M | 50,000 | 5.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $12.9M | 350,000 | 5.5% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $11.1M | 1,850,000 | 4.7% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $10.9M | 85,000 | 4.7% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $9.6M | 450,000 | 4.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.2M | 800,000 | 3.9% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $9.1M | 200,000 | 3.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $8.3M | 1,300,000 | 3.5% |
| Karuna Therapeutics Inc | COM | 48576A100 | $7.9M | 40,000 | 3.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.7M | 160,000 | 3.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $7.1M | 55,000 | 3.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $6.7M | 450,000 | 2.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $5.8M | 20,000 | 2.5% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $5.5M | 300,000 | 2.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.8M | 165,000 | 2.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $4.7M | 85,000 | 2.0% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $4.2M | 400,000 | 1.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $4.0M | 135,000 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.8M | 150,000 | 1.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.8M | 300,000 | 1.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.6M | 225,000 | 1.1% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $2.5M | 125,000 | 1.1% |
| Kezar Life Sciences Inc | COM | 49372L100 | $2.4M | 339,907 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $2.2M | 100,000 | 0.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.2M | 80,000 | 0.5% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $1.2M | 90,000 | 0.5% |
| Prometheus Biosciences Inc | COM | 74349U108 | $1.1M | 9,896 | 0.5% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $993.0K | 1,000,000 | 0.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $876.0K | 20,000 | 0.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $850.0K | 82,853 | 0.4% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $360.0K | 800,000 | 0.2% |